日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
World
Home / World / Europe

UK approves antiviral treatment for COVID-19

By ANGUS McNEICE in London | China Daily Global | Updated: 2020-06-02 10:24
Share
Share - WeChat

The United Kingdom medicines regulator has approved the use of remdesivir, an antiviral drug that is thought to shorten the recovery time for COVID-19 patients.

The drug, which is developed by California-based pharmaceutical company Gilead Sciences, will only be used in adults and adolescents who are hospitalized with severe symptoms of novel coronavirus infection.

Early trials of the drug suggest it can improve the recovery time for patients with severe symptoms of COVID-19 by up to four days.

"This is probably the biggest step forward in the treatment of coronavirus since the crisis began," Health Minister Matt Hancock said at a UK government news conference. "These are very early steps, but we are determined to support the science and back the projects that show promise."

The UK's Medicines and Healthcare products Regulatory Agency, or MHRA, approved the drug under its Early Access to Medicines Scheme, or EAMS.The scheme was created to provide access to promising yet unlicensed drugs for patients with life threatening conditions.

"We are committed to ensuring that patients can have fast access to promising new treatments for COVID-19," said MHRA Chief Executive June Raine. "We will continue to work closely with the Department of Health and Social Care and other healthcare partners on protecting public health in the UK by prioritizing our essential work on clinical trials, access to medicines, and the development of vaccines."

Remdesivir was created in 2009 as a drug to treat hepatitis C. The drug showed limited efficacy against hepatitis, and similarly was ineffective against Ebola virus disease and Marburg virus infections.

However, the drug later showed promising results against several other viruses including coronaviruses.

Remdesivir has been used in several COVID-19 trials since January. Patients given remdesivir had a 31 percent shorter recovery time versus placebo, according to a study in April by the National Institutes of Health, which is an agency of the United States Department of Health.

That trial involved 1,063 hospitalized patients with advanced COVID-19 infection, and the median time to recovery was 11 days for patients on remdesivir, compared with 15 days for those without it.

"This shows fantastic progress," said James Bethell, who is parliamentary Under-Secretary of State for Innovation at the UK Department of Health and Social Care. "As we navigate this unprecedented period, we must be on the front foot of the latest medical advancements, while always ensuring patient safety remains a top priority. The latest, expert scientific advice is at the heart of every decision we make, and we will continue to monitor remdesivir's success in clinical trials across the country to ensure the best results for UK patients."

The drug has also been authorized for emergency use in the US and Japan.

Most Viewed in 24 Hours
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
主站蜘蛛池模板: 星际迷航4| 久久影院在线观看 | 日本黄色免费片 | 夜夜狠狠操| 日韩精品视频免费在线观看 | 亚欧免费视频一区二区三区 | 中国人xxxxx18| 一区二区三区中文字幕 | 性爽爽| 看中国国产一级毛片真人视频 | 久久a区| 日本免费精品视频 | 92精品国产自产在线 | 久久天天躁夜夜躁狠狠 | 日日a.v拍夜夜添久久免费 | 99热这里只有精品国产99 | 亚州av在线 | 青青热久久国产久精品秒播 | 午夜视频在线 | 天天影院 | 天天干天天操天天做 | 91新视频| 都市妖奇谈 电视剧 | 久久久久久久国产精品 | 天天亚洲 | 亚久久| 精品三级国产精品经典三 | 日韩毛片网 | 亚洲视频在线观看网站 | 国产精品成熟老女人 | 日本高清免费h色视频在线观看 | 国产69精品久久久久99尤物 | 91久久艹 | 夜夜夜爽bbbb性视频 | 日本中文字幕一区二区有码在线 | 午夜免费视频 | 久久永久免费中文字幕 | 91看片网| 欧美一级网站 | 免费一级毛片在线播放视频 | 99热久久这里只有精品首页 |